EM1607E "Topics in Anticoagulation" (IM GR-072916)

To discuss important recommendations from the January 2016 Chest Guidelines for Antithrombotic Therapy for VTE Disease and the evidence comparing warfarin with the novel oral anticoagulants in the treatment of venous thromboembolism and atrial fibrillation.

Download Protocol

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Make reasoned treatment decisions on length of therapy for unprovoked venous thromboembolism
  • Be familiar with the major trials comparing warfarin and the novel oral anticoagulants(NOAC)
  • State the internet resources for estimating bleeding risk and managing bleeding in a patient on a NOAC
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
08/03/2016
Course expires: 
09/02/2016
Cost:
$0.00

Photo: Eric Steen, M.D.Eric Steen, M.D.
Professor
Division of General Internal Medicine

Available Credit

  • 1.00 AMA

Accreditation Period

Course opens: 
08/03/2016
Course expires: 
09/02/2016

Price

Cost:
$0.00
Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome